BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33310296)

  • 1. Antitumor effects and mechanisms of CpG ODN combined with attenuated Salmonella-delivered siRNAs against PD-1.
    Jia X; Guo J; Guo S; Zhao T; Liu X; Cheng C; Wang L; Zhang B; Meng C; Jia H; Luo E
    Int Immunopharmacol; 2021 Jan; 90():107052. PubMed ID: 33310296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide.
    Zhao T; Wei T; Guo J; Wang Y; Shi X; Guo S; Jia X; Jia H; Feng Z
    Cell Death Dis; 2019 Feb; 10(3):164. PubMed ID: 30778049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade.
    Li T; Hua C; Yue W; Wu J; Lv X; Wei Q; Zhu S; Zang G; Cui J; Liu YJ; Chen J
    Pharmacol Res; 2020 Nov; 161():105293. PubMed ID: 33176206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide.
    Jia H; Guo J; Wang P; Sun K; Chen J; Ren W; Wei T; Yang Y; Li J; Liu X; Li R; Zhong J; Wang M; Tian Z; Feng Z; Zhao T
    Int Immunopharmacol; 2020 Jun; 83():106397. PubMed ID: 32220805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
    Molavi O; Ma Z; Hamdy S; Lai R; Lavasanifar A; Samuel J
    Immunol Cell Biol; 2008; 86(6):506-14. PubMed ID: 18392040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases.
    Sfondrini L; Sommariva M; Tortoreto M; Meini A; Piconese S; Calvaruso M; Van Rooijen N; Bonecchi R; Zaffaroni N; Colombo MP; Tagliabue E; Balsari A
    Int J Cancer; 2013 Jul; 133(2):383-93. PubMed ID: 23319306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy.
    Heo MB; Kim SY; Yun WS; Lim YT
    Int J Nanomedicine; 2015; 10():5981-92. PubMed ID: 26451105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma.
    Pradhan P; Qin H; Leleux JA; Gwak D; Sakamaki I; Kwak LW; Roy K
    Biomaterials; 2014 Jul; 35(21):5491-504. PubMed ID: 24720881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.
    Switaj T; Jalili A; Jakubowska AB; Drela N; Stoksik M; Nowis D; Basak G; Golab J; Wysocki PJ; Mackiewicz A; Sasor A; Socha K; Jakóbisiak M; Lasek W
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4165-75. PubMed ID: 15217954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1.
    Yin P; Liu X; Mansfield AS; Harrington SM; Li Y; Yan Y; Dong H
    Oncotarget; 2016 Oct; 7(43):70223-70231. PubMed ID: 27602959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.
    Zhao T; Feng Y; Guo M; Zhang C; Wu Q; Chen J; Guo S; Liu S; Zhou Q; Wang Z; Fan W; Zhang Y; Jia H; Feng Z
    J Cell Biochem; 2020 Feb; 121(2):1973-1985. PubMed ID: 31692041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
    Yuan S; Qiao T; Chen W
    Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma.
    Wang X; Liu P; Liu H; Yang W; Liu Z; Zhuo Z; Gao Y
    Cancer Gene Ther; 2012 Dec; 19(12):822-7. PubMed ID: 23018621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid co-expressing siRNA-PD-1 and Endostatin carried by attenuated Salmonella enhanced the anti-melanoma effect via inhibiting the expression of PD-1 and VEGF on tumor-bearing mice.
    Wei T; Li Y; Li B; Xie Q; Huang Y; Wu Z; Chen H; Meng Y; Liang L; Wang M; Geng J; Lei M; Shang J; Guo S; Yang Z; Jia H; Ren F; Zhao T
    Int Immunopharmacol; 2024 Jan; 127():111362. PubMed ID: 38103411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy.
    Kigasawa K; Kajimoto K; Nakamura T; Hama S; Kanamura K; Harashima H; Kogure K
    J Control Release; 2011 Mar; 150(3):256-65. PubMed ID: 21256903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.
    Zhang M; Yin T; Lu Y; Feng H
    Med Sci Monit; 2016 Apr; 22():1309-17. PubMed ID: 27092689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
    Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
    Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.
    Kortylewski M; Kujawski M; Herrmann A; Yang C; Wang L; Liu Y; Salcedo R; Yu H
    Cancer Res; 2009 Mar; 69(6):2497-505. PubMed ID: 19258507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.